
Reset all filters
01 4Pfizer Canada ULC
Reset all filters
01 22690953
02 22983387
Reset all filters
01 4GLASDEGIB MALEATE
Reset all filters
01 4TABLET
Reset all filters
01 22028-06-16
02 22036-04-13
Patent Expiration Date : 2028-06-16
Date Granted : 2012-10-02
Brand Name : DAURISMO
Patent Number : 2690953
Filing Date : 2008-06-16
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-06-16
Date Granted : 2012-10-02
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-04-13
Date Granted : 2022-08-16
Brand Name : DAURISMO
Patent Number : 2983387
Filing Date : 2016-04-13
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-04-13
Date Granted : 2022-08-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-06-16
Date Granted : 2012-10-12
Brand Name : DAURISMO
Patent Number : 2690953
Filing Date : 2008-06-16
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-06-16
Date Granted : 2012-10-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2036-04-13
Date Granted : 2022-08-16
Brand Name : DAURISMO
Patent Number : 2983387
Filing Date : 2016-04-13
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2036-04-13
Date Granted : 2022-08-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF